Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | +2.86% | +19.43% | +66.15% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.15% | 469M | |
-1.40% | 104B | |
+7.46% | 97.47B | |
+5.71% | 22.25B | |
-12.82% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.71% | 16.36B | |
+8.38% | 14.39B | |
+39.57% | 12.37B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Larimar Therapeutics : JMP Securities Adjusts Price Target on Larimar Therapeutics to $30 From $43, Maintains Market Outperform Rating